Loading...

Margaret Fang, MD

TitleAssociate Professor
SchoolUCSF School of Medicine
DepartmentMedicine
Address533 Parnassus Avenue
San Francisco CA 94117
Phone415-502-7100
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Northwestern UniversityBA, Molecular/Cell Biology, Honors Program in Medical Education1994
    Northwestern University School of MedicineMD1998
    Beth Israel Deaconess Medical CenterInternship/Residency2001Medicine
    Massachusetts General HospitalGeneral Medicine Fellowship2003
    Harvard School of Public HealthMPH2003
    Collapse Awards and Honors
    Society of Hospital Medicine2010Excellence in Research Award
    NIH, AFAR2006Paul B. Beeson Career Development Award In Aging Research
    Society of General Internal Medicine2005Milton W. Hamolsky Award for best research abstract
    California Society of General Internal Medicine2005Clinician Investigator of the Year
    AGS Foundation for Health In Aging2005Hartford Geriatrics Health Outcomes Research Scholar
    American Heart Association2004Elizabeth Barrett-Connor Young Investigator Award
    Massachusetts American College of Physicians2002Associate of the Year
    Beth Israel Deaconess Medical Center2001Lowell McGee Award for top resident teacher
    American College of Physicians2001Joseph E. Johnson National Leadership and Recognition Award
    Beth Israel Deaconess Medical Center2000James Tullis Award for exceptional intellectual enthusiasm
    Northwestern University Medical School1997Jonathan Phillip Reder Award for excellence in academic and extracurricular activities
    Northwestern University1994A&O Award for Upcoming Student Leader

    Collapse Overview 
    Collapse Overview
    Margaret C. Fang is an Associate Professor of Medicine at the UCSF and joined the UCSF Division of Hospital Medicine in 2003. She is a graduate of the Honors Program in Medical Education at Northwestern University Medical School and trained in internal medicine at the Beth Israel Deaconess Medical Center in Boston. Subsequently, she completed a General Medicine Fellowship at the Massachusetts General Hospital and a Masters of Public Health at the Harvard School of Public Health.

    Margaret is the Medical Director of the UCSF Anticoagulation Clinic and devotes the majority of her time towards evaluating the quality, safety, and outcomes associated with anticoagulation therapy, with a particular focus on how to optimize the use of anticoagulants among older adults. She is a member of the ATRIA Study Group, investigating thromboembolic and hemorrhagic outcomes in a cohort of people with atrial fibrillation as well as the lead investigator of the CVRN Venous Thromboembolism Study, a cohort of patients with venous thromboembolic disease. Other research projects include investigating the use of genomic testing to guide warfarin dosing, the use of antithrombotic therapy among people undergoing orthopedic surgery, and assessing trends in risk factors and outcomes related to acute stroke.


    Collapse Research 
    Collapse Research Activities and Funding
    The Comparative Effectiveness of Warfarin and New Oral Anticoagulants for the Extended Treatment of Venous Thromboembolism
    Patient-Centered Outcomes Research Institute (PCORI) NOACS-1510-32651Nov 1, 2016 - Dec 31, 2020
    Role: Principal Investigator
    Improving Hospital Outcomes through Patient Engagement: The i-HOPE Study
    Patient-Centered Outcomes Research Institute (PCORI) Nov 1, 2016 - Oct 31, 2018
    Role: Co-Principal Investigator
    Management of Perioperative Anticoagulant Care and Transitions
    UCOP Center for Health Quality and Innovations Jul 1, 2013 - Jun 30, 2016
    Role: Principal Investigator
    Estimating Hemorrhage Risk in Patients with Atrial Fibrillation
    UCSF Clinical and Translational Sciences Institute Jun 1, 2012 - Jun 30, 2013
    Role: Principal Investigator
    Anticoagulation Treatment and Long-Term Outcomes After Venous Thromboembolism
    NIH/NHLBI R01HL103820Sep 1, 2010 - May 31, 2015
    Role: Principal Investigator
    Contemporary Treatment and Outcomes for Atrial Fibrillation in Clinical Practice
    NIH RC2HL101589Sep 30, 2009 - Jul 31, 2012
    Role: Co-Investigator
    Clarification of Optimal Anticoagulation through Genetics Study
    NIH/NHLBI May 1, 2009 - Apr 30, 2015
    Role: Co-Investigator
    Expanding the National Health Accounts
    NIH P01AG031098Feb 1, 2009 - Jan 31, 2015
    Role: Co-Investigator
    Risks of Warfarin for Elders with Atrial Fibrillation
    NIH/NIA K23AG028978Sep 1, 2006 - Aug 31, 2012
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Websites
    Collapse In The News
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Schwartz J, Merrill S, de Leon N, Thompson A, Fang M. Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center. J Hosp Med. 2017 Jul; 12(7):544-550. PMID: 28699943.
      View in: PubMed
    2. Chu JN, Maselli J, Auerbach AD, Fang M. The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty. Thromb Res. 2017 Jul; 155:65-71. PMID: 28501678.
      View in: PubMed
    3. Reading SR, Go AS, Fang M, Singer DE, Liu IA, Black MH, Udaltsova N, Reynolds K. Health Literacy and Awareness of Atrial Fibrillation. J Am Heart Assoc. 2017 Apr 11; 6(4). PMID: 28400367.
      View in: PubMed
    4. Parks AL, Fang M. Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding. Semin Thromb Hemost. 2017 Mar 30. PMID: 28359135.
      View in: PubMed
    5. Monash B, Najafi N, Mourad M, Rajkomar A, Ranji SR, Fang M, Glass M, Milev D, Ding Y, Shen A, Sharpe BA, Harrison JD. Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial. J Hosp Med. 2017 Mar; 12(3):143-149. PMID: 28272589.
      View in: PubMed
    6. McGrath ER, Go AS, Chang Y, Borowsky LH, Fang M, Reynolds K, Singer DE. Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke. J Am Geriatr Soc. 2016 Dec 30. PMID: 28039855.
      View in: PubMed
    7. Ashburner JM, Go AS, Chang Y, Fang M, Fredman L, Applebaum KM, Singer DE. Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study. J Am Geriatr Soc. 2016 Nov 12. PMID: 27861698.
      View in: PubMed
    8. Dallalzadeh LO, Go AS, Chang Y, Borowsky LH, Fang M, Singer DE. Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. J Am Heart Assoc. 2016; 5(7). PMID: 27451456.
      View in: PubMed
    9. Rajkomar A, McCulloch CE, Fang M, et al. The Low Diagnostic Utility of Rechecking Hemoglobins within 24 Hours in Hospitalized Patients. Am J Med. 2016 Jul 21. PMID: 27452681.
      View in: PubMed
    10. Quinn GR, Singer DE, Chang Y, Go AS, Borowsky LH, Fang M. How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation? Am J Cardiol. 2016 Sep 1; 118(5):697-9. PMID: 27394408.
      View in: PubMed
    11. Patel H, Fang M, Harrison JD, Auerbach A, Kangelaris KN, et al. Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group. J Hosp Med. 2016 Jun 13. PMID: 27294477.
      View in: PubMed
    12. Quinn GR, Fang M. How can I predict bleeding in my elderly patient taking anticoagulants? Cleve Clin J Med. 2016 May; 83(5):345-8. PMID: 27168509.
      View in: PubMed
    13. Fang M, Fan D, Sung SH, Witt DM, Schmelzer JR, Steinhubl SR, Yale SH, Go AS. Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study. Med Care. 2016 Feb 25. PMID: 26918401.
      View in: PubMed
    14. Parks AL, Fang M. Anticoagulation in Older Adults with Multimorbidity. Clin Geriatr Med. 2016 May; 32(2):331-46. PMID: 27113150.
      View in: PubMed
    15. Samuelson B, Go AS, Sung SH, Fan D, Fang M. Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study. J Hosp Med. 2016 Jun; 11(6):432-4. PMID: 27253585.
      View in: PubMed
    16. Ashburner JM, Go AS, Chang Y, Fang M, Fredman L, Applebaum KM, Singer DE. Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study. J Am Coll Cardiol. 2016 Jan 26; 67(3):239-47. PMID: 26796386.
      View in: PubMed
    17. Delate T, Hsiao W, Kim B, Witt DM, Meyer MR, Go AS, Fang M. Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism. Thromb Res. 2016 Jan; 137:97-102. PMID: 26585762.
      View in: PubMed
    18. Meyer MR, Witt DM, Delate T, Johnson SG, Fang M, Go A, Clark NP. Thrombophilia testing patterns amongst patients with acute venous thromboembolism. Thromb Res. 2015 Dec; 136(6):1160-4. PMID: 26477821.
      View in: PubMed
    19. Fang M, Fan D, Sung SH, Witt DM, Yale SH, Steinhubl SR, Go AS. Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study. JAMA Intern Med. 2015 Jun; 175(6):1060-2. PMID: 25894761.
      View in: PubMed
    20. Fang M. Implications of the new atrial fibrillation guideline. JAMA Intern Med. 2015 May; 175(5):850-1. PMID: 25730502.
      View in: PubMed
    21. Parekh AM, Fang M. Care as a continuum: will hospital outcomes be influenced by outpatient care? J Hosp Med. 2015 Feb; 10(2):133-4. PMID: 25545772.
      View in: PubMed
    22. Freeman JV, Reynolds K, Fang M, Udaltsova N, Steimle A, Pomernacki NK, Borowsky LH, Harrison TN, Singer DE, Go AS. Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study. Circ Arrhythm Electrophysiol. 2015 Feb; 8(1):49-58. PMID: 25414270; PMCID: PMC4334705 [Available on 02/01/16].
      View in: PubMed, PubMed Central
    23. Ashburner JM, Go AS, Reynolds K, Chang Y, Fang M, Fredman L, Applebaum KM, Singer DE. Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts). Am J Cardiol. 2015 Jan 1; 115(1):40-6. PMID: 25456871.
      View in: PubMed
    24. Lewis WR, Piccini JP, Turakhia MP, Curtis AB, Fang M, Suter RE, Page RL, Fonarow GC. Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes. 2014 Sep; 7(5):770-7. PMID: 25185244.
      View in: PubMed
    25. Goldsweig AM, Reid KJ, Gosch K, Tang F, Fang M, Maddox TM, Chan PS, Cohen DJ, Chen J. Contemporary use of dual antiplatelet therapy for preventing cardiovascular events. Am J Manag Care. 2014 Aug; 20(8):659-65. PMID: 25295680; PMCID: PMC4539274.
      View in: PubMed, PubMed Central
    26. Quinn GR, Singer DE, Chang Y, Go AS, Borowsky LH, Udaltsova N, Fang M. Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin. Am J Cardiol. 2014 Aug 15; 114(4):583-6. PMID: 25001151.
      View in: PubMed
    27. Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, Fang M, Fisher M, Furie KL, Heck DV, Johnston SC, Kasner SE, Kittner SJ, Mitchell PH, Rich MW, Richardson D, Schwamm LH, Wilson JA. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014 Jul; 45(7):2160-236. PMID: 24788967.
      View in: PubMed
    28. Fang M, Coca Perraillon M, Ghosh K, Cutler DM, Rosen AB. Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008. Am J Med. 2014 Jul; 127(7):608-15. PMID: 24680794; PMCID: PMC4125206.
      View in: PubMed, PubMed Central
    29. Fang M, Go AS, Chang Y, Borowsky LH, Pomernacki NK, Udaltsova N, Singer DE. Long-term survival after ischemic stroke in patients with atrial fibrillation. Neurology. 2014 Mar 25; 82(12):1033-7. PMID: 24532273; PMCID: PMC3962998.
      View in: PubMed, PubMed Central
    30. Shoeb M, Khanna R, Fang M, Sharpe B, Finn K, Ranji S, Monash B. Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies. J Hosp Med. 2014 Apr; 9(4):239-43. PMID: 24493566.
      View in: PubMed
    31. Kimmel SE, French B, Kasner SE, Johnson JA, Anderson JL, Gage BF, Rosenberg YD, Eby CS, Madigan RA, McBane RB, Abdel-Rahman SZ, Stevens SM, Yale S, Mohler ER, Fang M, Shah V, Horenstein RB, Limdi NA, Muldowney JA, Gujral J, Delafontaine P, Desnick RJ, Ortel TL, Billett HH, Pendleton RC, Geller NL, Halperin JL, Goldhaber SZ, Caldwell MD, Califf RM, Ellenberg JH. A pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med. 2013 Dec 12; 369(24):2283-93. PMID: 24251361; PMCID: PMC3942158.
      View in: PubMed, PubMed Central
    32. Auerbach A, Fang M, Glasheen J, Brotman D, O'Leary KJ, Horwitz LI. BOOST: evidence needing a lift. J Hosp Med. 2013 Aug; 8(8):468-9. PMID: 23873749.
      View in: PubMed
    33. Singer DE, Chang Y, Borowsky LH, Fang M, Pomernacki NK, Udaltsova N, Reynolds K, Go AS. A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score. J Am Heart Assoc. 2013 Jun; 2(3):e000250. PMID: 23782923; PMCID: PMC3698792.
      View in: PubMed, PubMed Central
    34. Shoeb M, Fang M. Assessing bleeding risk in patients taking anticoagulants. J Thromb Thrombolysis. 2013 Apr; 35(3):312-9. PMID: 23479259; PMCID: PMC3888359.
      View in: PubMed, PubMed Central
    35. Quinn GR, Fang M. Atrial fibrillation: stroke prevention in older adults. Clin Geriatr Med. 2012 Nov; 28(4):617-34. PMID: 23101573.
      View in: PubMed
    36. Fang M, Go AS, Chang Y, Borowsky LH, Pomernacki NK, Udaltsova N, Singer DE. Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants. Stroke. 2012 Jul; 43(7):1795-9. PMID: 22539546; PMCID: PMC3383879.
      View in: PubMed, PubMed Central
    37. You JJ, Singer DE, Howard PA, Lane DA, Eckman MH, Fang M, Hylek EM, Schulman S, Go AS, Hughes M, Spencer FA, Manning WJ, Halperin JL, Lip GY. Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb; 141(2 Suppl):e531S-75S. PMID: 22315271; PMCID: PMC3278056.
      View in: PubMed, PubMed Central
    38. Fang M. Selecting the optimal stroke prevention therapy in atrial fibrillation. Ann Intern Med. 2011 Nov 1; 155(9):636-7. PMID: 22041953.
      View in: PubMed
    39. Khanna RR, Karliner LS, Eck M, Vittinghoff E, Koenig CJ, Fang M. Performance of an online translation tool when applied to patient educational material. J Hosp Med. 2011 Nov; 6(9):519-25. PMID: 22034196.
      View in: PubMed
    40. Rennke S, Fang M. Hazards of hospitalization: more than just "never events". Arch Intern Med. 2011 Oct 10; 171(18):1653-4. PMID: 21824939.
      View in: PubMed
    41. Fang M, Go AS, Chang Y, Borowsky LH, Pomernacki NK, Udaltsova N, Singer DE. A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. J Am Coll Cardiol. 2011 Jul 19; 58(4):395-401. PMID: 21757117; PMCID: PMC3175766.
      View in: PubMed, PubMed Central
    42. Fang M, Maselli J, Lurie JD, Lindenauer PK, Pekow PS, Auerbach AD. Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery. J Thromb Haemost. 2011 Jul; 9(7):1318-25. PMID: 21535390; PMCID: PMC3129495.
      View in: PubMed, PubMed Central
    43. Fang M. Anticoagulation in people with atrial fibrillation. BMJ. 2011; 342:d530. PMID: 21282259.
      View in: PubMed
    44. Fang M, Go AS, Chang Y, Borowsky LH, Pomernacki NK, Udaltsova N, Singer DE. Warfarin discontinuation after starting warfarin for atrial fibrillation. Circ Cardiovasc Qual Outcomes. 2010 Nov; 3(6):624-31. PMID: 20959565; PMCID: PMC3063305.
      View in: PubMed, PubMed Central
    45. Singer DE, Fang M, Go AS. CHA2DS2-VASc risk scheme: not ready for clinical use. Chest. 2010 Oct; 138(4):1020; author reply 1020-1. PMID: 20923808.
      View in: PubMed
    46. Fang M, Cutler DM, Rosen AB. Trends in thrombolytic use for ischemic stroke in the United States. J Hosp Med. 2010 Sep; 5(7):406-9. PMID: 20578049; PMCID: PMC3024589.
      View in: PubMed, PubMed Central
    47. Sliwka D, Fang M. Venous thromboembolism prophylaxis in the United States: still room for improvement. J Gen Intern Med. 2010 Jun; 25(6):484-6. PMID: 20390463; PMCID: PMC2869419.
      View in: PubMed, PubMed Central
    48. Kneeland PP, Fang M. Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism. Patient Prefer Adherence. 2010; 4:51-60. PMID: 20361065; PMCID: PMC2846139.
      View in: PubMed, PubMed Central
    49. Mission JF, Kerlan RK, Tan JH, Fang M. Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients. J Gen Intern Med. 2010 Apr; 25(4):321-5. PMID: 20087675; PMCID: PMC2842553.
      View in: PubMed, PubMed Central
    50. Singer DE, Fang M, Go AS. The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation. Arch Intern Med. 2009 Nov 23; 169(21):2032; author reply 2033. PMID: 19933969.
      View in: PubMed
    51. Singer DE, Chang Y, Fang M, Borowsky LH, Pomernacki NK, Udaltsova N, Go AS. The net clinical benefit of warfarin anticoagulation in atrial fibrillation. Ann Intern Med. 2009 Sep 1; 151(5):297-305. PMID: 19721017; PMCID: PMC2777526.
      View in: PubMed, PubMed Central
    52. Kneeland PP, Fang M. Trends in catheter ablation for atrial fibrillation in the United States. J Hosp Med. 2009 Sep; 4(7):E1-5. PMID: 19753578; PMCID: PMC2919218.
      View in: PubMed, PubMed Central
    53. Singer DE, Chang Y, Fang M, Borowsky LH, Pomernacki NK, Udaltsova N, Go AS. Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study. Circ Cardiovasc Qual Outcomes. 2009 Jul; 2(4):297-304. PMID: 20031854; PMCID: PMC2801892.
      View in: PubMed, PubMed Central
    54. Go AS, Fang M, Udaltsova N, Chang Y, Pomernacki NK, Borowsky L, Singer DE. Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Circulation. 2009 Mar 17; 119(10):1363-9. PMID: 19255343; PMCID: PMC2733238.
      View in: PubMed, PubMed Central
    55. Fang M, Panguluri P, Machtinger EL, Schillinger D. Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication. Patient Educ Couns. 2009 Jun; 75(3):403-10. PMID: 19171448; PMCID: PMC2740646.
      View in: PubMed, PubMed Central
    56. Fang M. Antithrombotic therapy for the treatment of atrial fibrillation in the elderly. J Interv Card Electrophysiol. 2009 Jun; 25(1):19-23. PMID: 19148730.
      View in: PubMed
    57. Singer DE, Albers GW, Dalen JE, Fang M, Go AS, Halperin JL, Lip GY, Manning WJ. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008 Jun; 133(6 Suppl):546S-592S. PMID: 18574273.
      View in: PubMed
    58. Fang M, Go AS, Chang Y, Borowsky L, Pomernacki NK, Singer DE. Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation. J Am Coll Cardiol. 2008 Feb 26; 51(8):810-5. PMID: 18294564; PMCID: PMC3534960.
      View in: PubMed, PubMed Central
    59. Fang M, Chen J, Rich MW. Atrial fibrillation in the elderly. Am J Med. 2007 Jun; 120(6):481-7. PMID: 17524745.
      View in: PubMed
    60. Fang M, Go AS, Chang Y, Hylek EM, Henault LE, Jensvold NG, Singer DE. Death and disability from warfarin-associated intracranial and extracranial hemorrhages. Am J Med. 2007 Aug; 120(8):700-5. PMID: 17679129; PMCID: PMC3534961.
      View in: PubMed, PubMed Central
    61. Arora V, Fang M, Kripalani S, Amin AN. Preparing for "diastole": advanced training opportunities for academic hospitalists. J Hosp Med. 2006 Nov; 1(6):368-77. PMID: 17219531.
      View in: PubMed
    62. Fang M, Go AS, Hylek EM, Chang Y, Henault LE, Jensvold NG, Singer DE. Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study. J Am Geriatr Soc. 2006 Aug; 54(8):1231-6. PMID: 16913990; PMCID: PMC3534958.
      View in: PubMed, PubMed Central
    63. Fang M, Machtinger EL, Wang F, Schillinger D. Health literacy and anticoagulation-related outcomes among patients taking warfarin. J Gen Intern Med. 2006 Aug; 21(8):841-6. PMID: 16881944; PMCID: PMC1831580.
      View in: PubMed, PubMed Central
    64. Fang M, Singer DE, Chang Y, Hylek EM, Henault LE, Jensvold NG, Go AS. Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study. Circulation. 2005 Sep 20; 112(12):1687-91. PMID: 16157766; PMCID: PMC3522521.
      View in: PubMed, PubMed Central
    65. Go AS, Fang M, Singer DE. Antithrombotic therapy for stroke prevention in atrial fibrillation. Prog Cardiovasc Dis. 2005 Sep-Oct; 48(2):108-24. PMID: 16253651.
      View in: PubMed
    66. Fang M, Minichiello T, Auerbach AD. Cost considerations surrounding current and future anticoagulant therapies. Cleve Clin J Med. 2005 Apr; 72 Suppl 1:S43-9. PMID: 15853179.
      View in: PubMed
    67. Fang M, Chang Y, Hylek EM, Rosand J, Greenberg SM, Go AS, Singer DE. Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med. 2004 Nov 16; 141(10):745-52. PMID: 15545674.
      View in: PubMed
    68. Fang M, McCarthy EP, Singer DE. Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine. Am J Med. 2004 Oct 15; 117(8):575-81. PMID: 15465506.
      View in: PubMed
    69. Fang M, Singer DE. Anticoagulation for atrial fibrillation. Cardiol Clin. 2004 Feb; 22(1):47-62. PMID: 14994847.
      View in: PubMed
    70. Fang M, Stafford RS, Ruskin JN, Singer DE. National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation. Arch Intern Med. 2004 Jan 12; 164(1):55-60. PMID: 14718322.
      View in: PubMed
    Margaret's Networks
    Concepts
    Derived automatically from this person's publications.
    See all (167) concept(s)
    _
    Co-Authors
    People in Profiles who have published with this person.
    See all (25) people
    _
    Related Authors
    People who share related concepts with this person.
    See all (60) people
    _
    Back to TOP